S
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A14.6 KBSCIELE PHARMA, INC.Feb 13, 7:34 AM ET·0000766524-09-000043
- SC 13G/A34.2 KBSCIELE PHARMA, INC.Feb 3, 12:45 PM ET·0000913414-09-000347
- 8-K206.2 KBSCIELE PHARMA, INC.Aug 27, 3:01 PM ET·0001104659-08-055435
- 45.1 KBSCIELE PHARMA, INC.May 19, 4:07 PM ET·0001104659-08-034341
- 411.2 KBSCIELE PHARMA, INC.May 19, 4:05 PM ET·0001104659-08-034338
- 8-K235.2 KBSCIELE PHARMA, INC.Apr 30, 4:43 PM ET·0001104659-08-028454
- SC 13G37.4 KBSCIELE PHARMA, INC.Feb 6, 12:21 PM ET·0000913414-08-004334
- SC 13G30.4 KBSCIELE PHARMA, INC.Feb 1, 5:45 PM ET·0001085146-08-000219
- SC 13G/A128.0 KBSCIELE PHARMA, INC.Jan 23, 3:57 PM ET·0001104659-08-004091
- 8-K42.0 KBSCIELE PHARMA, INC.Jan 4, 10:28 AM ET·0001104659-08-000579
Insiders
10- Ciaffoni JosephExecutive V.P. & CCO
- Dillaha LarryEVP & Chief Medical Officer
- ELLIS JERRY NDirector
- FOURTEAU PATRICKCEO and President
- KAPOOR JOHN NDirector, 10% Owner
- LAPALME PIERREDirector
- Roberts AlanVP - Scientific Affairs
- SAXE JON SDirector
- SCHUTTER EDWARD JEVP & Chief Commercial Officer
- ZENNER PATRICK JDirector
Tickers
No tickers on record
Addresses
business
FIVE CONCOURSE PARKWAY SUITE 1800
ATALANTA, GA, 30328
mailing
FIVE CONCOURSE PARKWAY SUITE 1800
ATALANTA, GA, 30328
Former Names
- FIRST HORIZON PHARMACEUTICAL CORP2006-07-26